Ingevity Stock Price, News & Analysis (NYSE:NGVT)

$74.62 0.79 (1.07 %)
(As of 01/18/2018 07:07 AM ET)
Previous Close$73.83
Today's Range$73.29 - $75.41
52-Week Range$51.83 - $80.18
Volume190,700 shs
Average Volume228,764 shs
Market Capitalization$3.11 billion
P/E Ratio33.61
Dividend YieldN/A
Beta1.93

About Ingevity (NYSE:NGVT)

Ingevity logoIngevity Corporation is a manufacturer of specialty chemicals and high performance carbon materials. The Company is also a manufacturer of activated carbon used in gasoline vapor emission control systems in cars, trucks, motorcycles and boats. The Company operates through two segments: Performance Materials and Performance Chemicals. The Performance Materials segment primarily produces automotive carbon products used in gasoline vapor emission control systems in cars, trucks, motorcycles and boats. The Performance Chemicals segment develops, manufactures and sells a range of specialty chemicals primarily derived from co-products of the Kraft pulping process. Its products are used in a range of applications, including asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, publication inks and automotive components that reduce gasoline vapor emissions.

Receive NGVT News and Ratings via Email

Sign-up to receive the latest news and ratings for NGVT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Commodity Chemicals
Sub-IndustryN/A
SectorBasic Materials
SymbolNYSE:NGVT
CUSIPN/A
Phone843-740-2300

Debt

Debt-to-Equity Ratio1.92%
Current Ratio2.36%
Quick Ratio1.34%

Price-To-Earnings

Trailing P/E Ratio33.6126126126126
Forward P/E Ratio29.97
P/E Growth2.12

Sales & Book Value

Annual Sales$908.30 million
Price / Sales3.46
Cash Flow$3.04 per share
Price / Cash24.52
Book Value$3.20 per share
Price / Book23.32

Profitability

Trailing EPS$2.22
Net Income$35.20 million
Net Margins9.86%
Return on Equity58.14%
Return on Assets12.09%

Miscellaneous

Employees1,500
Outstanding Shares42,120,000

Ingevity (NYSE:NGVT) Frequently Asked Questions

What is Ingevity's stock symbol?

Ingevity trades on the New York Stock Exchange (NYSE) under the ticker symbol "NGVT."

How were Ingevity's earnings last quarter?

Ingevity Corp (NYSE:NGVT) announced its earnings results on Wednesday, November, 1st. The company reported $0.86 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.75 by $0.11. The business had revenue of $264.10 million for the quarter, compared to analysts' expectations of $260.88 million. Ingevity had a return on equity of 58.14% and a net margin of 9.86%. The firm's revenue was up 4.6% on a year-over-year basis. During the same period in the prior year, the business posted $0.64 earnings per share. View Ingevity's Earnings History.

When will Ingevity make its next earnings announcement?

Ingevity is scheduled to release their next quarterly earnings announcement on Wednesday, February, 28th 2018. View Earnings Estimates for Ingevity.

Where is Ingevity's stock going? Where will Ingevity's stock price be in 2018?

5 Wall Street analysts have issued 1 year price objectives for Ingevity's shares. Their forecasts range from $67.00 to $90.00. On average, they anticipate Ingevity's stock price to reach $79.20 in the next twelve months. View Analyst Ratings for Ingevity.

What are Wall Street analysts saying about Ingevity stock?

Here are some recent quotes from research analysts about Ingevity stock:

  • 1. According to Zacks Investment Research, "Ingevity Corporation provides specialty chemicals, carbon materials and technologies. The Company's operating segments consists of Performance Materials and Performance Chemicals. Performance Chemicals segment products consists of asphalt paving, adhesives, agrochemical dispersants, printing inks, lubricants, petroleum and other diverse industries. Performance Materials segment engineers, manufactures and sells wood-based chemically activated carbon products. Ingevity Corporation is based in North Charleston, SC. " (1/3/2018)
  • 2. Jefferies Group LLC analysts commented, "The introduction of a tighter fuel vapor emission standard by the European Union, and the likely tightening of standards in China, should accelerate activated carbon in 2019-2020. Near-term, the US shift to a near-zero standard will support Performance Materials revenue. Industrial specialties pricing remains weak, but a rebound in energy sales and strength in pavement technologies should support Performance Chemicals sales. Q4 results: Q4 EPS of $0.34 was $0.04 above consensus but $0.02 below our projections." (2/25/2017)

Who are some of Ingevity's key competitors?

Who are Ingevity's key executives?

Ingevity's management team includes the folowing people:

  • Richard B. Kelson, Independent Chairman of the Board (Age 70)
  • D. Michael Wilson, President, Chief Executive Officer, Director (Age 54)
  • John C. Fortson, Chief Financial Officer, Executive Vice President, Treasurer (Age 49)
  • Katherine Pryor Burgeson J.D., Executive Vice President, General Counsel, Secretary (Age 59)
  • Michael P, Smith, Executive Vice President and President, Performance Chemicals, Strategy and Business Development (Age 56)
  • S. Edward Woodcock Jr., Senior Vice President and President of Performance Materials (Age 51)
  • Dan Gallagher, Vice President, Financial Planning & Analysis and Investor Relations
  • Jean S. Blackwell, Independent Director (Age 62)
  • Luis Fernandez-Moreno, Independent Director (Age 54)
  • J. Michael Fitzpatrick, Independent Director (Age 70)

Who owns Ingevity stock?

Ingevity's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Copper Rock Capital Partners LLC (1.00%), Schwab Charles Investment Management Inc. (0.62%), Convergence Investment Partners LLC (0.13%), Gateway Investment Advisers LLC (0.09%), Louisiana State Employees Retirement System (0.04%) and Sheets Smith Wealth Management (0.01%). View Institutional Ownership Trends for Ingevity.

Who sold Ingevity stock? Who is selling Ingevity stock?

Ingevity's stock was sold by a variety of institutional investors in the last quarter, including Bank of Montreal Can and Convergence Investment Partners LLC. View Insider Buying and Selling for Ingevity.

Who bought Ingevity stock? Who is buying Ingevity stock?

Ingevity's stock was purchased by a variety of institutional investors in the last quarter, including Copper Rock Capital Partners LLC, Schwab Charles Investment Management Inc., Gateway Investment Advisers LLC, Sheets Smith Wealth Management and Louisiana State Employees Retirement System. View Insider Buying and Selling for Ingevity.

How do I buy Ingevity stock?

Shares of Ingevity can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Ingevity's stock price today?

One share of Ingevity stock can currently be purchased for approximately $74.62.

How big of a company is Ingevity?

Ingevity has a market capitalization of $3.11 billion and generates $908.30 million in revenue each year. The company earns $35.20 million in net income (profit) each year or $2.22 on an earnings per share basis. Ingevity employs 1,500 workers across the globe.

How can I contact Ingevity?

Ingevity's mailing address is 5255 VIRGINIA AVENUE, NORTH CHARLESTON SC, 29406. The company can be reached via phone at 843-740-2300 or via email at [email protected]


MarketBeat Community Rating for Ingevity (NGVT)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  106 (Vote Outperform)
Underperform Votes:  95 (Vote Underperform)
Total Votes:  201
MarketBeat's community ratings are surveys of what our community members think about Ingevity and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Ingevity (NYSE:NGVT) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.002.80
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $79.20$79.20$69.80$65.00
Price Target Upside: 11.63% upside1.06% upside0.22% upside11.47% upside

Ingevity (NYSE:NGVT) Consensus Price Target History

Price Target History for Ingevity (NYSE:NGVT)

Ingevity (NYSE:NGVT) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
12/26/2017Loop CapitalLower Price TargetBuy$83.00 -> $80.00LowView Rating Details
11/30/2017RoweReiterated RatingOutperform$80.00 -> $90.00MediumView Rating Details
11/3/2017Jefferies GroupBoost Price TargetBuy$71.00 -> $84.00N/AView Rating Details
10/5/2017KeyCorpReiterated RatingBuy$70.00 -> $75.00N/AView Rating Details
7/4/2017AegisReiterated RatingBuy$67.00LowView Rating Details
12/15/2016OppenheimerReiterated RatingOutperform$50.00 -> $60.00N/AView Rating Details
9/23/2016Buckingham ResearchInitiated CoverageNeutralN/AView Rating Details
8/6/2016SunTrust BanksReiterated RatingBuyN/AView Rating Details
6/10/2016BB&TInitiated CoverageBuy$44.00N/AView Rating Details
(Data available from 1/18/2016 forward)

Earnings

Ingevity (NYSE:NGVT) Earnings History and Estimates Chart

Earnings by Quarter for Ingevity (NYSE:NGVT)

Ingevity (NYSE NGVT) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/20/2018$0.36N/AView Earnings Details
11/1/2017Q3 2017$0.75$0.86$260.88 million$264.10 millionViewN/AView Earnings Details
8/2/2017Q2 2017$0.70$0.78$259.56 million$260.30 millionViewN/AView Earnings Details
5/3/2017Q1 2017$0.47$0.49$206.90 million$218.50 millionViewListenView Earnings Details
2/22/2017Q416$0.30$0.34$201.96 million$210.90 millionViewN/AView Earnings Details
11/2/2016Q316$0.61$0.64$247.60 million$252.00 millionViewN/AView Earnings Details
8/3/2016Q216$0.49$0.66$246.70 million$248.70 millionViewN/AView Earnings Details
5/31/2016Q1 2016$0.19ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Ingevity (NYSE:NGVT) Earnings Estimates

Current Year EPS Consensus Estimate: $2.49 EPS
Next Year EPS Consensus Estimate: $2.9 EPS

Dividends

Dividend History for Ingevity (NYSE:NGVT)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Ingevity (NYSE NGVT) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 0.06%
Institutional Ownership Percentage: 91.32%
Insider Trades by Quarter for Ingevity (NYSE:NGVT)
Institutional Ownership by Quarter for Ingevity (NYSE:NGVT)

Ingevity (NYSE NGVT) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/15/2017Jean S BlackwellDirectorBuy1,500$58.38$87,570.004,711View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Ingevity (NYSE NGVT) News Headlines

Source:
DateHeadline
Ingevity announces dates for fourth quarter and full year earnings release and conference call, upcoming Investor DayIngevity announces dates for fourth quarter and full year earnings release and conference call, upcoming Investor Day
finance.yahoo.com - January 16 at 5:26 PM
 Analysts Expect Ingevity Corp (NGVT) Will Post Quarterly Sales of $210.65 Million Analysts Expect Ingevity Corp (NGVT) Will Post Quarterly Sales of $210.65 Million
www.americanbankingnews.com - January 14 at 8:12 AM
$0.36 Earnings Per Share Expected for Ingevity Corp (NGVT) This Quarter$0.36 Earnings Per Share Expected for Ingevity Corp (NGVT) This Quarter
www.americanbankingnews.com - January 12 at 11:28 AM
Ingevity Corp (NGVT) Receives Consensus Recommendation of "Buy" from AnalystsIngevity Corp (NGVT) Receives Consensus Recommendation of "Buy" from Analysts
www.americanbankingnews.com - January 11 at 1:10 AM
Ingevity prices $300 million senior notes offeringIngevity prices $300 million senior notes offering
finance.yahoo.com - January 9 at 6:23 PM
BRIEF-Ingevity Announces Proposed Private Offering Of Senior Unsecured NotesBRIEF-Ingevity Announces Proposed Private Offering Of Senior Unsecured Notes
www.reuters.com - January 8 at 9:38 AM
Ingevity announces proposed private offering of senior unsecured notesIngevity announces proposed private offering of senior unsecured notes
finance.yahoo.com - January 8 at 9:38 AM
Ingevity (NGVT) & Verenium (VRNM) Head to Head ComparisonIngevity (NGVT) & Verenium (VRNM) Head to Head Comparison
www.americanbankingnews.com - January 8 at 1:30 AM
Head to Head Comparison: Trecora Resources (TREC) and Ingevity (NGVT)Head to Head Comparison: Trecora Resources (TREC) and Ingevity (NGVT)
www.americanbankingnews.com - January 7 at 9:40 PM
Stocks Showing Rising Market Leadership: Ingevity Earns 84 RS RatingStocks Showing Rising Market Leadership: Ingevity Earns 84 RS Rating
finance.yahoo.com - January 5 at 5:14 PM
Head to Head Survey: Ingevity (NGVT) and Airgas (ARG)Head to Head Survey: Ingevity (NGVT) and Airgas (ARG)
www.americanbankingnews.com - January 4 at 5:12 AM
Ingevity (NGVT) Downgraded by Zacks Investment ResearchIngevity (NGVT) Downgraded by Zacks Investment Research
www.americanbankingnews.com - January 3 at 2:15 PM
Ingevity (NGVT) and Methanex (MEOH) Financial SurveyIngevity (NGVT) and Methanex (MEOH) Financial Survey
www.americanbankingnews.com - December 29 at 3:24 PM
Loop Capital Cuts Ingevity (NGVT) Price Target to $80.00Loop Capital Cuts Ingevity (NGVT) Price Target to $80.00
www.americanbankingnews.com - December 26 at 10:38 AM
Reviewing Koppers (KOP) & Ingevity (NGVT)Reviewing Koppers (KOP) & Ingevity (NGVT)
www.americanbankingnews.com - December 25 at 11:42 PM
The Zacks Analyst Blog Highlights: Kronos Worldwide, Kraton, Ingevity, W. R. Grace and Arkema S.A.The Zacks Analyst Blog Highlights: Kronos Worldwide, Kraton, Ingevity, W. R. Grace and Arkema S.A.
finance.yahoo.com - December 21 at 8:36 AM
Financial Analysis: Ingevity (NGVT) vs. Its RivalsFinancial Analysis: Ingevity (NGVT) vs. Its Rivals
www.americanbankingnews.com - December 18 at 11:50 AM
Ingevity Corporation (NGVT) Receives Consensus Rating of "Buy" from AnalystsIngevity Corporation (NGVT) Receives Consensus Rating of "Buy" from Analysts
www.americanbankingnews.com - December 17 at 1:50 AM
Ingevity (NGVT) & Its Rivals Head to Head AnalysisIngevity (NGVT) & Its Rivals Head to Head Analysis
www.americanbankingnews.com - December 15 at 5:26 PM
Contrasting Ingevity (NGVT) & Its PeersContrasting Ingevity (NGVT) & Its Peers
www.americanbankingnews.com - December 15 at 3:30 PM
Ingevity Corp. – Value Analysis (NYSE:NGVT) : December 14, 2017Ingevity Corp. – Value Analysis (NYSE:NGVT) : December 14, 2017
finance.yahoo.com - December 14 at 6:00 PM
Contrasting Ingevity (NGVT) & The CompetitionContrasting Ingevity (NGVT) & The Competition
www.americanbankingnews.com - December 14 at 1:30 PM
Ingevity (NGVT) vs. Its Competitors Head to Head AnalysisIngevity (NGVT) vs. Its Competitors Head to Head Analysis
www.americanbankingnews.com - December 13 at 7:24 PM
Ingevity Corp. breached its 50 day moving average in a Bearish Manner : NGVT-US : December 13, 2017Ingevity Corp. breached its 50 day moving average in a Bearish Manner : NGVT-US : December 13, 2017
finance.yahoo.com - December 13 at 8:46 AM
Innophos (IPHS) and Ingevity (NGVT) Head to Head SurveyInnophos (IPHS) and Ingevity (NGVT) Head to Head Survey
www.americanbankingnews.com - December 11 at 9:30 PM
Ingevity Corporation (NGVT) Expected to Announce Quarterly Sales of $210.65 MillionIngevity Corporation (NGVT) Expected to Announce Quarterly Sales of $210.65 Million
www.americanbankingnews.com - December 11 at 10:58 AM
Analyzing Ingevity (NGVT) and Its PeersAnalyzing Ingevity (NGVT) and Its Peers
www.americanbankingnews.com - December 8 at 5:36 AM
Comparing Ingevity (NGVT) and Its PeersComparing Ingevity (NGVT) and Its Peers
www.americanbankingnews.com - December 7 at 11:34 AM
Comparing Enzymotec (ENZY) & Ingevity (NGVT)Comparing Enzymotec (ENZY) & Ingevity (NGVT)
www.americanbankingnews.com - December 7 at 1:24 AM
Contrasting Ingevity (NGVT) & CSW Industrials (CSWI)Contrasting Ingevity (NGVT) & CSW Industrials (CSWI)
www.americanbankingnews.com - December 6 at 2:46 PM
Ingevity (NGVT) vs. Its Competitors Head to Head ReviewIngevity (NGVT) vs. Its Competitors Head to Head Review
www.americanbankingnews.com - December 6 at 3:12 AM
CF Industries (CF) Subsidiary Redeems Senior Notes Due 2018CF Industries (CF) Subsidiary Redeems Senior Notes Due 2018
www.zacks.com - December 4 at 8:30 AM
Ingevity (NGVT) versus NewMarket (NEU) Financial ContrastIngevity (NGVT) versus NewMarket (NEU) Financial Contrast
www.americanbankingnews.com - December 3 at 5:30 PM
Reviewing Quaker Chemical (KWR) & Ingevity (NGVT)Reviewing Quaker Chemical (KWR) & Ingevity (NGVT)
www.americanbankingnews.com - December 3 at 11:44 AM
Contrasting Ingevity (NGVT) and Westlake Chemical Partners (WLKP)Contrasting Ingevity (NGVT) and Westlake Chemical Partners (WLKP)
www.americanbankingnews.com - December 3 at 9:56 AM
Reviewing Ingevity (NGVT) and Its PeersReviewing Ingevity (NGVT) and Its Peers
www.americanbankingnews.com - December 2 at 8:46 AM
Head to Head Review: Ingevity (NGVT) & Its PeersHead to Head Review: Ingevity (NGVT) & Its Peers
www.americanbankingnews.com - November 30 at 9:32 PM
Rowe Reaffirms Outperform Rating for Ingevity (NGVT)Rowe Reaffirms Outperform Rating for Ingevity (NGVT)
www.americanbankingnews.com - November 30 at 9:51 AM
Ingevity to open new automotive testing center in Zhuhai, ChinaIngevity to open new automotive testing center in Zhuhai, China
finance.yahoo.com - November 30 at 9:31 AM
Celanese (CE) Set to Raise Acetaldehyde Price in EuropeCelanese (CE) Set to Raise Acetaldehyde Price in Europe
finance.yahoo.com - November 30 at 8:39 AM
NGVT Crosses Above Average Analyst TargetNGVT Crosses Above Average Analyst Target
www.nasdaq.com - November 29 at 6:29 PM
Eastman Chemical Tritan Picked for Panasonic Food ProcessorsEastman Chemical Tritan Picked for Panasonic Food Processors
finance.yahoo.com - November 29 at 8:28 AM
Kraton Corp (KRA) Up 46% in 3 Months: Whats Driving It?Kraton Corp (KRA) Up 46% in 3 Months: What's Driving It?
www.msn.com - November 28 at 10:20 AM
Celanese (CE) Shares Up 36% YTD: Whats Driving the Stock?Celanese (CE) Shares Up 36% YTD: What's Driving the Stock?
finance.yahoo.com - November 28 at 10:20 AM
Ingevity (NGVT) vs. Its Rivals Financial ReviewIngevity (NGVT) vs. Its Rivals Financial Review
www.americanbankingnews.com - November 25 at 11:04 PM
Ingevitys (NGVT) "Buy" Rating Reiterated at Loop CapitalIngevity's (NGVT) "Buy" Rating Reiterated at Loop Capital
www.americanbankingnews.com - November 25 at 4:12 PM
Innospec (IOSP) Up 27% in 3 Months: Whats Driving It?Innospec (IOSP) Up 27% in 3 Months: What's Driving It?
finance.yahoo.com - November 24 at 9:25 AM
Agrium Poised on Retail Expansion Amid Pricing ConcernsAgrium Poised on Retail Expansion Amid Pricing Concerns
www.zacks.com - November 24 at 9:25 AM
Zacks: Brokerages Expect Ingevity Corporation (NGVT) Will Post Quarterly Sales of $210.65 MillionZacks: Brokerages Expect Ingevity Corporation (NGVT) Will Post Quarterly Sales of $210.65 Million
www.americanbankingnews.com - November 23 at 8:32 AM
AK Steel Poised on Strategic Actions Amid Pricing PressureAK Steel Poised on Strategic Actions Amid Pricing Pressure
www.zacks.com - November 23 at 6:51 AM

SEC Filings

Ingevity (NYSE:NGVT) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Ingevity (NYSE:NGVT) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Ingevity (NYSE NGVT) Stock Chart for Thursday, January, 18, 2018

Loading chart…

This page was last updated on 1/18/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.